Nanobiotix Sa - Adr share price logo

Nanobiotix Sa - Adr Share Price

NASDAQ: NBTX

Small Cap

$25.70

-0.87

(-3.27%)

as on

Nanobiotix Sa - Adr Stock Performance

as on October 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $25.3
    $26.9
    downward going graph

    1.56%

    Downside

    4.67%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.76
    $30.35
    downward going graph

    89.26%

    Downside

    18.09%

    Upside

    downward going graph

Nanobiotix Sa - Adr share price movements today

Previous Close
$26.57
Open
$26.43
Volume
314.8K
Day's Low - High
$25.3 - $26.9
52 Week Low - High
$2.76 - $30.35

Nanobiotix Sa - Adr Historical Returns

1 Month Return
+ 121.26 %
3 Month Return
+ 383.02 %
1 Year Return
+ 441.23 %
3 Year Return
+ 570.16 %
5 Year Return
0 %

Nanobiotix Sa - Adr Stock Fundamentals & Key Indicators

Check Nanobiotix Sa - Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-0.29

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-43.8M

Revenue (TTM)

10.2M

Profit Margin

0.00%

Return On Equity TTM

55696100.00%

Nanobiotix Sa - Adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nanobiotix Sa - Adr with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Nanobiotix Sa - Adr image
Nanobiotix Sa - Adr
BUY$1.3BNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$63.1B240.52%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.3BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$106.9B94.28%29.6731.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$61.3B0.25%14.5831.37%

Stock Returns calculator for Nanobiotix Sa - Adr Stock including INR - Dollar returns

The Nanobiotix Sa - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Nanobiotix Sa - Adr investment value today

Current value as on today

₹5,48,071

Returns

₹4,48,071

(+448.07%)

Returns from Nanobiotix Sa - Adr Stock

₹4,43,340 (+443.34%)

Dollar Returns*

₹4,730 (+4.73%)

Analyst Recommendation on Nanobiotix Sa - Adr Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Nanobiotix Sa - Adr. Average target price of $15.17

Nanobiotix Sa - Adr Share Price Target

Get share price movements and forecasts by analysts on Nanobiotix Sa - Adr.

What analysts predicted

-69.41%DOWNSIDE

Target Price

$15.17

Current Price

$25.7

Analyzed by

10 Analysts

Target

$15.17

Nanobiotix Sa - Adr target price $15.17, a slight downside of -69.41% compared to current price of $25.7. According to 10 analysts rating.

Nanobiotix Sa - Adr Stock’s Investor Sentiment and Interest

Search interest for Nanobiotix Sa - Adr Stock has increased by 325% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:325% versus previous 30 day period

Nanobiotix Sa - Adr Quarterly Profit & Loss

All numbers in Millions USD

Jun 2022
Sep 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Mar 2025
Jun 2025
Total Revenue
0
1
1
3
16
32
9
-20
26
Gross Profit
0
1
1
3
16
32
9
-20
26
Operating Income
-26
-10
-24
-25
0
-1
-23
-44
0
EBITDA
-12
-10
-10
-24
0
1
-23
-35
1
Interest Expense
-
-
3
-
-
8
-
8
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-27
-15
-33
-28
-5
-11
-21
-46
-5
Income Tax Expense
-1
0
-3
0
0
0
0
0
0
Net Income
-27
-15
-32
-30
-5
-11
-21
-46
-5
Net Profit Margin
-3966.44%
-890.17%
-1780.33%
-853.29%
-35.25%
-35.25%
-235.46%
221.36%
-20.21%

Nanobiotix Sa - Adr Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
1
0
0
0
0
2
5
39
-12
Gross Profit
0
1
0
0
0
0
2
4
39
-12
Operating Income
-17
-21
-25
-30
-46
-36
-52
-46
-26
-68
EBITDA
-16
-21
-25
-29
-44
-31
-45
-44
-23
-58
Interest Expense
0
0
0
0
4
0
0
5
7
8
Depreciation
-
-
0
0
1
1
1
1
1
1
Income Before Tax
-17
-21
-26
-30
-50
-33
-46
-57
-39
-68
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-18
-23
-30
-34
-56
-40
-53
-60
-43
-71
Net Profit Margin
-6403.14%
-1404.31%
-10375.62%
-25772.41%
-74875.00%
-67246.00%
-1775.75%
-1194.37%
-109.64%
586.89%

Nanobiotix Sa - Adr Quarterly Cash Flow

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Mar 2025
Jun 2025
Net Income
-15
-30
-28
-5
-5
-11
-21
-46
-5
Operating Cash Flow
-9
-20
-17
2
-
4
-5
-13
-17
Investing Cash Flow
0
0
0
-
-
0
0
0
0
Financing Cash Flow
-1
-1
-1
24
-
48
-2
-2
-2
Change in Cash
-10
-24
-16
26
-
53
-4
54
28

Nanobiotix Sa - Adr Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-21
-26
-30
-50
-33
-47
-57
-39
-68
Operating Cash Flow
-18
-21
-25
-41
-27
-29
-37
-12
-19
Investing Cash Flow
0
-1
0
-1
0
0
0
0
0
Financing Cash Flow
22
48
14
41
111
-5
-5
46
-5
Change in Cash
4
26
-11
-1
84
-35
-42
33
-25

Global Institutional Holdings in Nanobiotix Sa - Adr

Funds
Holdings
Johnson & Johnson
11.66%
Geode Capital Management, LLC
0.02%
Morgan Stanley - Brokerage Accounts
0.01%
UBS Group AG
0.01%
BNP Paribas Arbitrage, SA
0%
See all

Nanobiotix Sa - Adr News & Key Events

  • img

    Today's Timeline - 18 September

    Thu, 05:52 PM

    -

    Nanobiotix's NBTXR3 shows promise in cancer treatment, receiving FDA Fast Track designation for head and neck cancer.

    Fri, 01:16 AM

    -

    Nanobiotix reports favorable Phase 1 study results for JNJ-1900 in melanoma, with a 47.4% objective response rate.

Insights on Nanobiotix Sa - Adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -46.26M → -5.38M (in $), with an average increase of 759.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -20.89M → 26.63M (in $), with an average increase of 178.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NBTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NBTX stock has moved up by 121.3%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NBTX has outperformed top 5 stocks with highest market-cap in its industry

About Nanobiotix Sa - Adr

nanobiotix (euronext: nano / isin: fr0011341205) is a late clinical-stage nanomedicine company pioneering novel approaches for the treatment of cancer. the company’s first-in-class, proprietary technology, nanoxray, enhances radiotherapy energy with a view to providing a new, more efficient treatment for cancer patients. nanoxray products are compatible with current radiotherapy treatments and are meant to treat potentially a wide variety of solid tumors including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, etc., via multiple routes of administration. nbtxr3 is being evaluated in: soft tissue sarcoma (sts), head and neck cancers, prostate cancer, and liver cancers (primary and metastases). additionally, head and neck cancer and rectal cancer trials led by nanobiotix’s taiwanese partner, pharmaengine, are underway in the asia pacific region. the company started a new preclinical research program in immuno-oncology with its lea
OrganisationNanobiotix Sa - Adr
Headquarters60 rue de Wattignies, Paris, France, 75012
IndustryHealthcare
CEOMr. Laurent Levy Ph.D.
E-voting on sharesClick here to vote

Key Management of Nanobiotix Sa - Adr

Name

Title

Mr. Earl J. Bergey Ph.d.

Co-Founder

Mr. Brandon Owens

VP of Strategic Marketing & Corporate Communication

Ms. Margaret Galluzzi

VP & Global Head of Clinical Operations

Dr. Leonard A. Farber M.D.

Chief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory Board

Mr. Laurent Levy Ph.D.

Co-Founder, President of the Executive Board & CEO

Mr. Bart Van Rhijn

Chief Financial & Business Officer and Member of Executive Board

Ms. Anne-Juliette Hermant M.A.

Chief People Officer & Member of Executive Board

Dr. Louis Kayitalire M.D.

Chief Medical Officer & Member of Executive Board

FAQs

What is Nanobiotix Sa - Adr share price today?

Nanobiotix Sa - Adr share price today is $25.7 as on at the close of the market. Nanobiotix Sa - Adr share today touched a day high of $26.9 and a low of $25.3.

What is the 52 week high and 52 week low for Nanobiotix Sa - Adr share?

Nanobiotix Sa - Adr share touched a 52 week high of $30.35 on and a 52 week low of $2.76 on . Nanobiotix Sa - Adr stock price today i.e. is closed at $25.7,which is 15.32% down from its 52 week high and 831.16% up from its 52 week low.

What is Nanobiotix Sa - Adr's market capitalisation today?

Nanobiotix Sa - Adr market capitalisation is $0.00T as on .

How to invest in Nanobiotix Sa - Adr Stock (NBTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nanobiotix Sa - Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nanobiotix Sa - Adr Shares that will get you 0.0584 shares as per Nanobiotix Sa - Adr share price of $25.7 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Nanobiotix Sa - Adr Stock (NBTX) from India?

Indian investors can start investing in Nanobiotix Sa - Adr (NBTX) shares with as little as ₹87.9 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.00 in Nanobiotix Sa - Adr stock (as per the Rupee-Dollar exchange rate as on ). Based on Nanobiotix Sa - Adr share’s latest price of $25.7 as on October 18, 2025 at 1:29 am IST, you will get 0.3891 shares of Nanobiotix Sa - Adr. Learn more about fractional shares .